文献速递青光眼白内障与屈光手术

Schlemm管微支架对白内障术后早期眼压的影响:HORIZON随机对照试验分析

Effect of a Schlemm's Canal Microstent on Early Postoperative Intraocular Pressure after Cataract Surgery: An Analysis of the HORIZON Randomized Controlled Trial.
PubMed 文献 · Ophthalmology · 2020-01-23

HORIZON随机对照试验的子分析比较了单纯白内障手术与联合Hydrus微支架植入术后早期眼压。共556眼随机分组,微支架组术后第1天眼压>40 mmHg发生率1.4%,显著低于单纯手术组的14.4%(P<0.001)。

要点

  • 联合微支架组术后第1天眼压>40 mmHg发生率为1.4%,单纯手术组为14.4%。
  • 微支架组术后第1天眼压较基线升高≥10 mmHg的发生率为3.0%,低于单纯手术组的22.5%。
  • 基线眼压较高预测术后第1天眼压>40 mmHg风险增加,微支架植入与风险降低相关。

核心结论

  • 白内障手术联合Hydrus微支架植入可降低青光眼患者术后早期眼压显著升高的风险。

研究设计与样本

  • HORIZON随机对照试验的子分析,多中心研究,纳入26个美国中心和12个国际中心。
  • 556眼随机按2:1分配至白内障手术联合Hydrus微支架组(369眼)或单纯白内障手术组(187眼)。
  • 纳入轻/中度原发性开角型青光眼合并白内障患者,洗脱后平均改良日间眼压22-34 mmHg。

主要发现

  • 术后第1天眼压>40 mmHg发生率:微支架组1.4%,单纯手术组14.4%(P<0.001)。
  • 术后第1天眼压较基线升高≥10 mmHg发生率:微支架组3.0%,单纯手术组22.5%(P<0.001)。
  • 术后第1天平均眼压:微支架组17.0 mmHg,单纯手术组27.6 mmHg(P<0.001)。
  • 多变量逻辑回归显示较高基线眼压预测术后第1天眼压>40 mmHg风险增加,微支架植入与风险降低相关。

关键数值与推荐

  • 主要结局为术后眼压>40 mmHg。
  • 次要结局包括眼压较基线升高>10 mmHg发生率、未用药眼压和平均眼压。
  • 术后未使用降眼压预防措施,术前洗脱降眼压药物。

临床怎么用

  • 对于合并轻/中度原发性开角型青光眼的白内障患者,联合Hydrus微支架植入可考虑用于降低术后早期眼压骤升风险。

局限性

  • 本文为HORIZON试验的子分析,早期术后眼压为分析重点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare early postoperative intraocular pressure (IOP) in patients who underwent cataract surgery alone with those who underwent cataract surgery combined with implantation of a Hydrus Microstent (HMS) (Ivantis, Irvine, CA). DESIGN: Subanalysis of data from the randomized controlled HORIZON trial, a multicenter trial including 26 US and 12 international sites. PARTICIPANTS: Participants with mild/moderate primary open-angle glaucoma (POAG) and visually significant cataract with mean modified diurnal IOP between 22 and 34 mmHg after washout of IOP-lowering medications. METHODS: A total of 556 subjects were randomized in a 2:1 ratio to undergo cataract surgery with placement of the HMS versus cataract surgery alone (no microstent [NMS]). All eyes were washed out of IOP-lowering medications before surgery and remained unmedicated until surgery. No IOP-lowering prophylaxis was used postoperatively. Comprehensive eye examination including measurement of intraocular pressure was conducted on postoperative day (POD) 1, week 1, and month 1. MAIN OUTCOME MEASURES: Postoperative IOP >40 mmHg was analyzed as the primary outcome. Incidence of IOP increase >10 mmHg above baseline, unmedicated IOP, and mean IOP were analyzed as secondary outcomes. RESULTS: A total of 369 eyes were randomized to the HMS group, and 187 eyes were randomized to cataract surgery alone. The HMS and NMS groups did not differ with respect to baseline demographic or ocular characteristics. On POD1, the incidence of IOP spike >40 mmHg was significantly higher at 14.4% in the NMS group compared with 1.4% in the HMS group (P < 0.001). The incidence of IOP increase ≥10 mmHg relative to baseline on POD1 was also significantly higher in the NMS group than in the HMS group (22.5% vs. 3.0%, P < 0.001). IOP in the NMS group was significantly higher than in the HMS group (27.6 vs. 17.0 mmHg, P < 0.001). In multivariable logistic regression analysis, higher baseline IOP predicted higher odds of POD1 IOP spike >40 mmHg, whereas the presence of HMS was associated with a lower likelihood of postoperative IOP spike. CONCLUSIONS: The addition of an HMS at the time of cataract surgery lowered the risk of markedly elevated IOP in the early postoperative period in patients with glaucoma.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Zebardast N, Zheng C, Jampel HD, et al. Effect of a Schlemm's Canal Microstent on Early Postoperative Intraocular Pressure after Cataract Surgery: An Analysis of the HORIZON Randomized Controlled Trial. Ophthalmology. 2020. PMID: 32143828. doi:10.1016/j.ophtha.2020.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。